Cargando…
The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice
Polygenic risk score analyses on embryos (PGT-P) are being marketed by some private testing companies to parents using in vitro fertilisation as being useful in selecting the embryos that carry the least risk of disease in later life. It appears that at least one child has been born after such a pro...
Autores principales: | Forzano, Francesca, Antonova, Olga, Clarke, Angus, de Wert, Guido, Hentze, Sabine, Jamshidi, Yalda, Moreau, Yves, Perola, Markus, Prokopenko, Inga, Read, Andrew, Reymond, Alexandre, Stefansdottir, Vigdis, van El, Carla, Genuardi, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090769/ https://www.ncbi.nlm.nih.gov/pubmed/34916614 http://dx.doi.org/10.1038/s41431-021-01000-x |
Ejemplares similares
-
Correction: The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice
por: Forzano, Francesca, et al.
Publicado: (2022) -
Reply to Letter by Tellier et al., ‘Scientific refutation of ESHG statement on embryo selection’
por: Forzano, Francesca, et al.
Publicado: (2022) -
Correction to: Reply to Letter by Tellier et al., ‘Scientific refutation of ESHG statement on embryo selection’
por: Forzano, Francesca, et al.
Publicado: (2022) -
Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia
por: McLean, Alison K, et al.
Publicado: (2015) -
Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia
por: McLean, Alison K, et al.
Publicado: (2015)